Cargando…

Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents

In the present paper, we report that mitosis is a key step in the cellular response to genotoxic agents in human cells. Cells with damaged DNA recruit γH2AX (phosphorylated histone H2AX), phosphorylate Chk1 (checkpoint kinase 1) and arrest in the G(2)-phase of the cell cycle. Strikingly, nearly all...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubara, Philip M., Kernéis-Golsteyn, Sophie, Studény, Aurélie, Lanser, Brittany B., Meijer, Laurent, Golsteyn, Roy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430003/
https://www.ncbi.nlm.nih.gov/pubmed/22686412
http://dx.doi.org/10.1042/BJ20120385
_version_ 1782241882794885120
author Kubara, Philip M.
Kernéis-Golsteyn, Sophie
Studény, Aurélie
Lanser, Brittany B.
Meijer, Laurent
Golsteyn, Roy M.
author_facet Kubara, Philip M.
Kernéis-Golsteyn, Sophie
Studény, Aurélie
Lanser, Brittany B.
Meijer, Laurent
Golsteyn, Roy M.
author_sort Kubara, Philip M.
collection PubMed
description In the present paper, we report that mitosis is a key step in the cellular response to genotoxic agents in human cells. Cells with damaged DNA recruit γH2AX (phosphorylated histone H2AX), phosphorylate Chk1 (checkpoint kinase 1) and arrest in the G(2)-phase of the cell cycle. Strikingly, nearly all cells escape the DNA damage checkpoint and become rounded, by a mechanism that correlates with Chk1 dephosphorylation. The rounded cells are alive and in mitosis as measured by low phospho-Tyr(15) Cdk1 (cyclin-dependent kinase 1), high Cdk activity, active Plk1 (Polo-like kinase 1) and high phospho-histone H3 signals. This phenomenon is independent of the type of DNA damage, but is dependent on pharmacologically relevant doses of genotoxicity. Entry into mitosis is likely to be caused by checkpoint adaptation, and the HT-29 cell-based model provides a powerful experimental system in which to explore its molecular basis. We propose that mitosis with damaged DNA is a biologically significant event because it may cause genomic rearrangement in cells that survive genotoxic damage.
format Online
Article
Text
id pubmed-3430003
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-34300032012-09-10 Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents Kubara, Philip M. Kernéis-Golsteyn, Sophie Studény, Aurélie Lanser, Brittany B. Meijer, Laurent Golsteyn, Roy M. Biochem J Research Article In the present paper, we report that mitosis is a key step in the cellular response to genotoxic agents in human cells. Cells with damaged DNA recruit γH2AX (phosphorylated histone H2AX), phosphorylate Chk1 (checkpoint kinase 1) and arrest in the G(2)-phase of the cell cycle. Strikingly, nearly all cells escape the DNA damage checkpoint and become rounded, by a mechanism that correlates with Chk1 dephosphorylation. The rounded cells are alive and in mitosis as measured by low phospho-Tyr(15) Cdk1 (cyclin-dependent kinase 1), high Cdk activity, active Plk1 (Polo-like kinase 1) and high phospho-histone H3 signals. This phenomenon is independent of the type of DNA damage, but is dependent on pharmacologically relevant doses of genotoxicity. Entry into mitosis is likely to be caused by checkpoint adaptation, and the HT-29 cell-based model provides a powerful experimental system in which to explore its molecular basis. We propose that mitosis with damaged DNA is a biologically significant event because it may cause genomic rearrangement in cells that survive genotoxic damage. Portland Press Ltd. 2012-08-28 2012-09-15 /pmc/articles/PMC3430003/ /pubmed/22686412 http://dx.doi.org/10.1042/BJ20120385 Text en © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kubara, Philip M.
Kernéis-Golsteyn, Sophie
Studény, Aurélie
Lanser, Brittany B.
Meijer, Laurent
Golsteyn, Roy M.
Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title_full Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title_fullStr Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title_full_unstemmed Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title_short Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents
title_sort human cells enter mitosis with damaged dna after treatment with pharmacological concentrations of genotoxic agents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430003/
https://www.ncbi.nlm.nih.gov/pubmed/22686412
http://dx.doi.org/10.1042/BJ20120385
work_keys_str_mv AT kubaraphilipm humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents
AT kerneisgolsteynsophie humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents
AT studenyaurelie humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents
AT lanserbrittanyb humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents
AT meijerlaurent humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents
AT golsteynroym humancellsentermitosiswithdamageddnaaftertreatmentwithpharmacologicalconcentrationsofgenotoxicagents